As an example: biotech companies in Spain are about 900, and 90% of them are SME and micro-SME, and their product development phases are very long, they need a lot of input of resources. Hence, these companies require very specific instruments of financing.
Lucía Reinoso, CFO at AMADIX, gives thank to Iberaval for the support that they offer to the SME companies in Spain, and specifically Castilla y León.
More News